Navigation Links
OriGene Technologies Announces the Release Specificity-Verified UltraMAB™ Antibodies
Date:3/20/2012

ROCKVILLE, Md., March 20, 2012 /PRNewswire/ -- OriGene Technologies today announced the release of a new line of ultra specific and extensively validated monoclonal antibodies under the UltraMAB™ brand. UltraMAB Antibodies are a collection of monoclonal antibodies which are exclusively developed by OriGene for IHC applications and are the industry's only antibody products available on the market that have been validated with the Company's breakthrough 10K High Density Protein Microarray Technology. OriGene's 10K High Density Protein Microarray Platform enables the screening of candidate antibodies against greater than 10,000 human proteins to identify the most specific monoclonal antibodies for IHC applications.

"High-specificity is the pre-requisite for any IHC antibody because IHC detection relies on only one antibody against a complex tissue sample. Through the use of novel and proprietary technologies such as our 10K High-Density Protein Microarray Platform, OriGene has dramatically improved the specificity of antibodies available to the global market place. By validating all UltraMAB antibodies against our 10K High-Density Protein Microarray Platform, the market now has access to one of the industry's most significant tools for IHC detection and determination of accurate results," said Dr. Wei-Wu He, Ph.D., CEO & Chairman, OriGene Technologies.

Each UltraMAB™ is validated for IHC and for immunoassay analysis, and determined to have no cross-reactivity with other human proteins other than the antibody's intended target protein as determined by OriGene's 10K High Density Protein Microarray Platform. Consequently, each UltraMAB™ is quality control verified, guaranteeing superior performance for IHC applications, where specificity-verification and the highest quality antibodies are critical for accurate detection.

Detailed information about the UltraMAB™ Antibodies is available at www.origene.com/UltraMAB, where customers can learn more about OriGene's unique approach to monoclonal antibody development and contact the company's representatives to explore collaborative opportunities.

OriGene will present the new line of UltraMAB™ Antibodies at the USCAP 2012 Annual Meeting in Vancouver, CA; March 17-23rd Booth # 827. To register for the company's free seminar presentation on UltraMAB™ please visit www.origene.com.

About OriGene Technologies

OriGene Technologies, Inc., is a biosciences company dedicated to develop gene centric innovative products and services to improve the quality of healthcare diagnostics and treatments. The Company's broadest collection of gene based products and services are important tools to accelerate the discovery of new diagnostics and drug treatments for better patient care. OriGene has one of the largest scale antibody production and highest quality process facilities in the world. For more information, visit www.OriGene.com.


'/>"/>
SOURCE OriGene Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program
2. Latest Cell Publication Describes the Novel Kinase Regulators Using OriGenes Functional Kinome Collection
3. Blue Belt Technologies to Showcase Navio™ PFS System at CAOS UK 2012 Conference in Glasgow, UK
4. Life Technologies Launches GeneArt® Precision TALs
5. BioStorage Technologies to Host Live Webinar on Optimizing the Value of Sample Assets
6. PLC Announces Ministry of Health Approval to Distribute RenalGuard® in Israel Through A.M.I. Technologies, Ltd.
7. Omnicell to Exhibit at Dubai International Pharmaceuticals and Technologies Conference and Exhibition
8. Palatin Technologies Completes Enrollment in Phase 2B Bremelanotide Female Sexual Dysfunction Trial
9. Biospace Lab and the Centre for Advanced Biomedical Imaging at University College London to Collaborate on Development of Novel Real-Time in Vivo Optical Imaging Technologies
10. Medical Care Technologies Inc. Announces Adjournment of Special Meeting
11. BioStorage Technologies Integrates Sample Preparation Services into European Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... and Orphan Diseases, today announced that President & CEO Gerald ... SeeThru Equity MicroCap Conference   Where: ... , NY When: Tuesday, May 31 st , ... Where: Grand Hyatt Hotel, 109 East 42 nd St, ...
(Date:5/26/2016)... , May 26, 2016 ... market growth is the emergence of new treatments. Cardax, ... therapies for osteoarthritis treatment. The therapy is expected to ... Arthritis Research UK is conducting studies to develop new ... study, where the genes involved in osteoarthritis are being ...
(Date:5/26/2016)... , May 26, 2016 Since ... matured into an essential life science tool for conducting ... applications. BCC Research reveals in its new report that ... growth phase, one powered by a range of new ...      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
Breaking Medicine Technology:
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... readers, this installment is bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities ... within the industry, from leading advocates, associations and industry leaders such as Bioness. ...
(Date:5/27/2016)... ... May 27, 2016 , ... Each year Standard Process ... Outerbridge is this year’s Life University winner of a $2,500 scholarship ... Student Leadership Awards ceremony. , Outerbridge is approaching her last quarter at Life ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot ... of defective respirators, according to court documents and SEC filings. A jury ... Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... The ... Project offering a new model of care for living and healing, celebrated its ... values: Meaningful Life in a Real Home provided by Empowered Staff. , “This is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James Maisel will present ... Island Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public Library. ... Retina Group of New York , is a Board Certified ophthalmologist who completed ...
Breaking Medicine News(10 mins):